This inventor holds 3 USPTO granted patents. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Other. Active years: 2000-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 915 
1 out of 834,570 Years Active: 2000-2005
Title: Innovations by Irina Marianovsky
Introduction
Irina Marianovsky is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of targeted therapy, particularly in the development of chimeric toxins for cancer treatment. With a total of 3 patents, her work has the potential to impact the medical community significantly.
Latest Patents
One of her latest patents is focused on chimeric toxins for targeted therapy. This invention relates to neoplastic cells targeted chimeric toxins that comprise cell targeting moieties and cell killing moieties. The cell targeting moieties consist of gonadotropin-releasing hormone homologues, while the cell killing moieties consist of Exotoxin A. The invention also includes pharmaceutical compositions containing these chimeric toxins and methods for their production. Furthermore, it outlines a method for cancer therapy, specifically targeting malignant carcinoma cells and benign hyperplasia, including various types of tumors.
Another significant patent involves pseudomonas exotoxin-myelin basic protein chimeric proteins. This chimeric protein comprises an exotoxin moiety linked to a myelin basic protein moiety. The invention is particularly useful in treating autoimmune diseases, especially multiple sclerosis. The detailed structure of the chimeric protein allows for targeted treatment, enhancing its therapeutic potential.
Career Highlights
Irina has worked with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her experience in this esteemed institution has allowed her to further her research and development in innovative medical therapies.
Collaborations
Irina has collaborated with notable individuals in her field, including Shai Yarkoni and Haya Lorberboum-Galski. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Irina Marianovsky's innovative work in the field of targeted therapy showcases her dedication to advancing medical science. Her patents reflect her commitment to developing effective treatments for cancer and autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile